Enabling microscale and nanoscale approaches for bioengineered cardiac tissue

Vincent Chan, Ritu Raman, Caroline Cvetkovic, Rashid Bashir

Research output: Contribution to journalArticle

Abstract

In this issue of ACS Nano, Shin et al. present their finding that the addition of carbon nanotubes (CNT) in gelatin methacrylate (GelMA) results in improved functionality of bioengineered cardiac tissue. These CNT-GelMA hybrid materials demonstrate cardiac tissue with enhanced electrophysiological performance; improved mechanical integrity; better cell adhesion, viability, uniformity, and organization; increased beating rate and lowered excitation threshold; and protective effects against cardio-inhibitory and cardio-toxic drugs. In this Perspective, we outline recent progress in cardiac tissue engineering and prospects for future development. Bioengineered cardiac tissues can be used to build "heart-on-a-chip" devices for drug safety and efficacy testing, fabricate bioactuators for biointegrated robotics and reverse-engineered life forms, treat abnormal cardiac rhythms, and perhaps one day cure heart disease with tissue and organ transplants.

Original languageEnglish (US)
Pages (from-to)1830-1837
Number of pages8
JournalACS Nano
Volume7
Issue number3
DOIs
StatePublished - Mar 26 2013

Fingerprint

microbalances
Tissue
Carbon Nanotubes
Methacrylates
gelatins
Gelatin
Carbon nanotubes
drugs
carbon nanotubes
heart diseases
rhythm
Transplants
tissue engineering
Poisons
Cell adhesion
Hybrid materials
robotics
Tissue engineering
viability
organs

ASJC Scopus subject areas

  • Materials Science(all)
  • Engineering(all)
  • Physics and Astronomy(all)

Cite this

Enabling microscale and nanoscale approaches for bioengineered cardiac tissue. / Chan, Vincent; Raman, Ritu; Cvetkovic, Caroline; Bashir, Rashid.

In: ACS Nano, Vol. 7, No. 3, 26.03.2013, p. 1830-1837.

Research output: Contribution to journalArticle

Chan, Vincent ; Raman, Ritu ; Cvetkovic, Caroline ; Bashir, Rashid. / Enabling microscale and nanoscale approaches for bioengineered cardiac tissue. In: ACS Nano. 2013 ; Vol. 7, No. 3. pp. 1830-1837.
@article{3b6411fc982d4f019957d71efda696b1,
title = "Enabling microscale and nanoscale approaches for bioengineered cardiac tissue",
abstract = "In this issue of ACS Nano, Shin et al. present their finding that the addition of carbon nanotubes (CNT) in gelatin methacrylate (GelMA) results in improved functionality of bioengineered cardiac tissue. These CNT-GelMA hybrid materials demonstrate cardiac tissue with enhanced electrophysiological performance; improved mechanical integrity; better cell adhesion, viability, uniformity, and organization; increased beating rate and lowered excitation threshold; and protective effects against cardio-inhibitory and cardio-toxic drugs. In this Perspective, we outline recent progress in cardiac tissue engineering and prospects for future development. Bioengineered cardiac tissues can be used to build {"}heart-on-a-chip{"} devices for drug safety and efficacy testing, fabricate bioactuators for biointegrated robotics and reverse-engineered life forms, treat abnormal cardiac rhythms, and perhaps one day cure heart disease with tissue and organ transplants.",
author = "Vincent Chan and Ritu Raman and Caroline Cvetkovic and Rashid Bashir",
year = "2013",
month = "3",
day = "26",
doi = "10.1021/nn401098c",
language = "English (US)",
volume = "7",
pages = "1830--1837",
journal = "ACS Nano",
issn = "1936-0851",
publisher = "American Chemical Society",
number = "3",

}

TY - JOUR

T1 - Enabling microscale and nanoscale approaches for bioengineered cardiac tissue

AU - Chan, Vincent

AU - Raman, Ritu

AU - Cvetkovic, Caroline

AU - Bashir, Rashid

PY - 2013/3/26

Y1 - 2013/3/26

N2 - In this issue of ACS Nano, Shin et al. present their finding that the addition of carbon nanotubes (CNT) in gelatin methacrylate (GelMA) results in improved functionality of bioengineered cardiac tissue. These CNT-GelMA hybrid materials demonstrate cardiac tissue with enhanced electrophysiological performance; improved mechanical integrity; better cell adhesion, viability, uniformity, and organization; increased beating rate and lowered excitation threshold; and protective effects against cardio-inhibitory and cardio-toxic drugs. In this Perspective, we outline recent progress in cardiac tissue engineering and prospects for future development. Bioengineered cardiac tissues can be used to build "heart-on-a-chip" devices for drug safety and efficacy testing, fabricate bioactuators for biointegrated robotics and reverse-engineered life forms, treat abnormal cardiac rhythms, and perhaps one day cure heart disease with tissue and organ transplants.

AB - In this issue of ACS Nano, Shin et al. present their finding that the addition of carbon nanotubes (CNT) in gelatin methacrylate (GelMA) results in improved functionality of bioengineered cardiac tissue. These CNT-GelMA hybrid materials demonstrate cardiac tissue with enhanced electrophysiological performance; improved mechanical integrity; better cell adhesion, viability, uniformity, and organization; increased beating rate and lowered excitation threshold; and protective effects against cardio-inhibitory and cardio-toxic drugs. In this Perspective, we outline recent progress in cardiac tissue engineering and prospects for future development. Bioengineered cardiac tissues can be used to build "heart-on-a-chip" devices for drug safety and efficacy testing, fabricate bioactuators for biointegrated robotics and reverse-engineered life forms, treat abnormal cardiac rhythms, and perhaps one day cure heart disease with tissue and organ transplants.

UR - http://www.scopus.com/inward/record.url?scp=84875650253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875650253&partnerID=8YFLogxK

U2 - 10.1021/nn401098c

DO - 10.1021/nn401098c

M3 - Article

C2 - 23527748

AN - SCOPUS:84875650253

VL - 7

SP - 1830

EP - 1837

JO - ACS Nano

JF - ACS Nano

SN - 1936-0851

IS - 3

ER -